UNIV OF NORTH CAROLINA CHAPEL HILL
Optimization of a potent and cell active CK2 chemical probe for Alzheimer's disease therapy
Optimization of a potent and cell active CK2 chemical probe for Alzheimer's disease therapy is a funding opportunity from UNIV OF NORTH CAROLINA CHAPEL HILL, up to 796443, closing August 31, 2027.
Aug 31, 2027
(396d left)Overview
Project Summary/Abstract Alzheimer’s disease (AD), the most common cause of progressive dementia in adults over the age of 65, is a devastating disorder without effective treatment options. Available drugs treat late-stage symptoms rather than addressing disease-causing pathways. There is an urgent need for new…